As ordered reported by the Senate Committee on Homeland Security and Governmental Affairs on September 25, 2024
By Fiscal Year, Millions of Dollars
2025
2025-2029
2025-2034
Direct Spending (Outlays)
0
0
0
Revenues
0
0
0
Increase or Decrease (-) in the Deficit
0
0
0
Spending Subject to Appropriation (Outlays)
5
143
293
Increases net direct spending in any of the four consecutive 10-year periods beginning in 2035?
No
Statutory pay-as-you-go procedures apply?
Yes
Mandate Effects
Increases on-budget deficits in any of the four consecutive 10-year periods beginning in 2035?
No
Contains intergovernmental mandate?
No
Contains private-sector mandate?
No
Summary
S. 4667 would establish the Life Sciences Research Security Board as an independent executive branch agency to review and approve federal funding requests for what is termed high-risk life sciences research, which involves pathogens that are particularly dangerous to humans. The board’s members would be appointed by the President and subject to Senate confirmation.
S. 4667 would require the board to receive funding proposals from federal agencies for projects or grant programs at least 30 days before a project or program is funded. Within 120 days, board members would be required to determine whether a proposal involves high‑risk life sciences research and, if so, whether the project requires biosafety controls to proceed. The board also could review and audit research projects using federal funds awarded before the bill’s enactment and could direct such funding to be suspended.